Form 8-K - Current report:
SEC Accession No. 0001437749-20-012348
Filing Date
2020-06-03
Accepted
2020-06-03 16:30:19
Documents
1
Period of Report
2020-06-02
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20200602_8k.htm 8-K 39919
  Complete submission text file 0001437749-20-012348.txt   41137
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 20940406
SIC: 2834 Pharmaceutical Preparations